Page last updated: 2024-10-29

iohexol and Carcinoma, Lobular

iohexol has been researched along with Carcinoma, Lobular in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Carcinoma, Lobular: A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amato, F1
Bicchierai, G1
Cirone, D1
Depretto, C1
Di Naro, F1
Vanzi, E1
Scaperrotta, G1
Bartolotta, TV1
Miele, V1
Nori, J1
Łuczyńska, E1
Heinze-Paluchowska, S1
Hendrick, E1
Dyczek, S1
Ryś, J1
Herman, K1
Blecharz, P1
Jakubowicz, J1

Trials

1 trial available for iohexol and Carcinoma, Lobular

ArticleYear
Comparison between breast MRI and contrast-enhanced spectral mammography.
    Medical science monitor : international medical journal of experimental and clinical research, 2015, May-12, Volume: 21

    Topics: Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltratin

2015

Other Studies

1 other study available for iohexol and Carcinoma, Lobular

ArticleYear
Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).
    La Radiologia medica, 2019, Volume: 124, Issue:12

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Lobular; Contrast Media; Female; Humans; Iohexol; Mammogra

2019